Dashboard
Manage Tickers

DVAX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-dynavax-technologies-maintains-29-price-target
HC Wainwright & Co. Reiterates Buy on Dyna...
06/28/2024 10:28:25

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

dynavax-initiates-phase-12-study-of-novel-shingles-vaccine-program-evaluating-safety-tolerability-and-immunogenicity-of-z-1018
Dynavax Initiates Phase 1/2 Study Of Novel...
06/27/2024 20:10:52

hc-wainwright--co-reiterates-buy-on-dynavax-technologies-maintains-29-price-target
HC Wainwright & Co. Reiterates Buy on Dyna...
05/14/2024 15:19:48

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

fda-declines-to-approve-expanded-use-of-dynavaxs-hepatitis-b-vaccine-in-hemodialysis-patients
FDA Declines To Approve Expanded Use of Dy...
05/14/2024 14:10:02

Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Respons...

fda-issued-complete-response-letter-to-dynavax-saying-sbla-for-four-dose-heplisav-b-regimen-did-not-provide-sufficient-data-to-support-full-evaluation-of-effectiveness-or-safety
FDA Issued Complete Response Letter To Dyn...
05/14/2024 12:35:48

hc-wainwright--co-reiterates-buy-on-dynavax-technologies-maintains-29-price-target
HC Wainwright & Co. Reiterates Buy on Dyna...
05/09/2024 10:50:33

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

dynavax-reaffirms-full-year-2024-financial-guidance-expects-cash--equivalents-to-be-higher-yy-at-december-31-2024
Dynavax Reaffirms Full Year 2024 Financial...
05/08/2024 20:56:05

HEPLISAV-B net product revenue between approximately $265 - $280 million, including approximately $3 million in ex-U.S. sales...

dynavax-technologies-q1-2024-gaap-eps-007-misses-003-estimate-sales-50790m-miss-54975m-estimate
Dynavax Technologies Q1 2024 GAAP EPS $(0....
05/08/2024 20:02:29

Dynavax Technologies (NASDAQ:DVAX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate o...

dynavax-technologies-sees-fy24-net-product-revenue-265m-280m-vs-290628m-est
Dynavax Technologies Sees FY24 Net Product...
02/22/2024 21:37:55

dynavax-technologies-q4-earnings-insights
Dynavax Technologies: Q4 Earnings Insights
02/22/2024 21:05:13

dynavax-technologies-q4-sales-5560m-beat-5273m-estimate
Dynavax Technologies Q4 Sales $55.60M Beat...
02/22/2024 21:02:35

Dynavax Technologies (NASDAQ:DVAX) reported quarterly sales of $55.60 million which beat the analyst consensus estimate of $52....

earnings-scheduled-for-february-22-2024
Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

goldman-sachs-initiates-coverage-on-dynavax-technologies-with-neutral-rating-announces-price-target-of-20
Goldman Sachs Initiates Coverage On Dynava...
02/01/2024 12:00:51

Goldman Sachs analyst Paul Choi initiates coverage on Dynavax Technologies (NASDAQ:DVAX) with a Neutral rating and announces...

why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session
Why RxSight Shares Are Trading Higher By 2...
01/08/2024 18:36:30

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

dynavax-sees-prelim-2023-heplisav-b-vaccine-net-product-revenue-213m-up-69-yoy-51m-for-q4-up-46-yoy
Dynavax Sees Prelim. 2023 HEPLISAV-B Vacci...
01/08/2024 14:06:12

jmp-securities-maintains-market-outperform-on-dynavax-technologies-raises-price-target-to-27
JMP Securities Maintains Market Outperform...
11/03/2023 19:43:00

JMP Securities analyst Roy Buchanan maintains Dynavax Technologies (NASDAQ:DVAX) with a Market Outperform and raises the pri...

hc-wainwright--co-maintains-buy-on-dynavax-technologies-raises-price-target-to-28
HC Wainwright & Co. Maintains Buy on Dynav...
11/03/2023 10:58:58

HC Wainwright & Co. analyst Edward White maintains Dynavax Technologies (NASDAQ:DVAX) with a Buy and raises the price ta...

dynavax-technologies-q3-eps-010-sales-6951m-beat-6030m-estimate
Dynavax Technologies Q3 EPS $0.10, Sales $...
11/02/2023 21:33:30

Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of ...

earnings-scheduled-for-november-2-2023
Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

earnings-preview-for-dynavax-technologies
Earnings Preview For Dynavax Technologies
11/01/2023 18:01:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)